What is the prevalence of Hydranencephaly?

TL;DR: Hydranencephaly is an extremely rare, life-limiting condition with an estimated incidence of approximately 1 in 10,000 to 1 in 25,000 live births. Because many cases result in pregnancy loss or early infant mortality, the number of individuals living with hydranencephaly is significantly lower than the incidence rate, classifying it as an ultra-rare condition.

How common is hydranencephaly?

Hydranencephaly is classified as an ultra-rare condition due to its low incidence and high mortality rate. While exact global prevalence is difficult to determine, clinical literature and records from the National Institutes of Health (NIH) GARD suggest that the incidence is roughly 1 in 10,000 to 1 in 25,000 births. It is important to note that these figures are estimates; because hydranencephaly is often detected via prenatal ultrasound, many cases are identified before birth, and the true incidence may be higher than recorded due to under-reporting or early pregnancy loss.

Are there demographic or geographic differences in prevalence?

Current clinical research does not indicate that hydranencephaly shows a preference for specific ethnic groups or geographic regions. The condition appears to occur sporadically worldwide. Regarding gender distribution, data suggests that hydranencephaly affects both males and females equally. Because the condition involves the near-total absence of the cerebral hemispheres, it is almost exclusively identified in the pediatric population; survival into adulthood is exceptionally rare, and most affected infants do not survive beyond the first year of life.

What challenges exist in tracking hydranencephaly statistics?

Accurate epidemiological data for hydranencephaly is hindered by several factors, including:

• Diagnostic Overlap: It is frequently confused with severe hydrocephalus, where the brain tissue is compressed rather than absent.


• Reporting Discrepancies: Because the condition is often terminal, many cases are categorized under pregnancy loss or neonatal mortality statistics rather than as specific rare disease diagnoses.


• Underdiagnosis: In regions with limited access to prenatal imaging or neonatal neurological evaluation, many cases may go undiagnosed.

How does the DiseaseMaps community reflect these numbers?

While large-scale epidemiological studies provide the "big picture," real-world data offers a personal perspective. Currently, 37 people with hydranencephaly have joined the DiseaseMaps.org community to share their experiences. This community data serves as a vital resource for families, as it highlights that even within an "ultra-rare" diagnosis, there is a global network of caregivers and families navigating the complexities of hydranencephaly together. These community members provide insights into the lived experience that clinical statistics alone cannot capture.

Next steps

• Consult with a pediatric neurologist or a neonatologist to discuss specific diagnostic findings and prognosis.


• Seek genetic counseling to understand the underlying causes, as some cases are linked to vascular accidents or intrauterine infections.


• Connect with the hydranencephaly community on DiseaseMaps.org to share support and resources with others who have direct experience with the condition.


• Request a referral to a palliative care team if you are navigating a new diagnosis, as they can provide essential support for both the child and the family.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Hydranencephaly.


• Orphanet: Rare disease database entry for Hydranencephaly (ORPHA: 2095).


• Online Mendelian Inheritance in Man (OMIM): Entry regarding Hydranencephaly.


• DiseaseMaps.org: Community-reported data for rare neurological conditions.